Correlation Between Stryker and Pacific Biosciences

Can any of the company-specific risk be diversified away by investing in both Stryker and Pacific Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Pacific Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stryker and Pacific Biosciences of, you can compare the effects of market volatilities on Stryker and Pacific Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Pacific Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Pacific Biosciences.

Diversification Opportunities for Stryker and Pacific Biosciences

0.17

Correlation Coefficient

Stryker  Pacific Biosciences

Average diversification

The 3 months correlation between Stryker and Pacific is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Pacific Biosciences of in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacific Biosciences and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Pacific Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacific Biosciences has no effect on the direction of Stryker i.e., Stryker and Pacific Biosciences go up and down completely randomly.

Pair Corralation between Stryker and Pacific Biosciences

Considering the 90-day investment horizon Stryker is expected to generate 193.86 times less return on investment than Pacific Biosciences. But when comparing it to its historical volatility, Stryker is 5.75 times less risky than Pacific Biosciences. It trades about 0.0 of its potential returns per unit of risk. Pacific Biosciences of is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  174.00  in Pacific Biosciences of on September 23, 2024 and sell it today you would earn a total of  23.00  from holding Pacific Biosciences of or generate 13.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Stryker  vs.  Pacific Biosciences of

Stryker

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stryker has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Stryker is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pacific Biosciences

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pacific Biosciences of are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Pacific Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Stryker and Pacific Biosciences

The main advantage of trading using opposite Stryker and Pacific Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Pacific Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacific Biosciences will offset losses from the drop in Pacific Biosciences' long position.

The idea behind Stryker and Pacific Biosciences of pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.